Doximity (NYSE: DOCS) is a leading digital health platform designed for medical professionals across the United States. The company provides doctors with essential tools for communication, news, and career management. Its main goal is to improve efficiency in the healthcare industry by connecting physicians and offering them innovative digital workflow solutions.
On May 13, 2026, Doximity reported its quarterly financial results. The company announced an earnings per share (EPS) of $0.26. This figure missed the analyst consensus estimate of $0.28, as highlighted by Zacks. This also marks a decline from the $0.38 per share reported in the same quarter of the previous year.
Despite the earnings miss, the company’s revenue performance showed strong growth. It posted revenues of $145.37 million for the quarter, which surpassed the estimated $144.03 million. This represents an increase from the year-ago revenues of $138.29 million and marks the fourth consecutive quarter the company has topped revenue estimates.
This revenue growth is supported by increasing user activity. Doximity achieved a new engagement record with over 800,000 active prescribers using its tools. CEO Jeff Tangney noted that prompts per user for its clinical AI nearly doubled from January to April, showing strong adoption of its new healthcare technology.
To further this growth, Doximity is partnering with Aledade and Photon to expand its AI suite's reach. The company also maintains a strong financial position. It has a very low debt-to-equity ratio of 0.01, indicating minimal debt, and a high current ratio of 6.09, which suggests it can easily cover its short-term obligations.
